Martina Almáši
- Hematology top 5%
- Multiple Myeloma Research and Treatments 22
-
- Cancer-related molecular mechanisms research 4
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 2
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Genomic variations and chromosomal abnormalities 2
-
- Glycosylation and Glycoproteins Research 3
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Luděk PourRoman HájekSabina Ševčı́kováPetr KuglíkMiroslav PenkaLenka SedlaříkováMartin ŠtorkViera Sandecká
- Partner nations
- CzechiaUnited StatesJapan
In The Last Decade
Martina Almáši
28 papers receiving 482 citations
Peers
Comparison fields: 5 of 69
- Hematology 291
- Cancer Research 136
- Biological Psychiatry 20
- Genetics 57
- Molecular Biology 342
Countries citing papers authored by Martina Almáši
This map shows the geographic impact of Martina Almáši's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Almáši with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Almáši more than expected).
Fields of papers citing papers by Martina Almáši
This network shows the impact of papers produced by Martina Almáši. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Almáši. The network helps show where Martina Almáši may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martina Almáši, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 6 | |
| 7 | 2019 | 29 | |
| 8 | 2018 | 12 | |
| 9 | 2017 | 62 | |
| 10 | 2017 | 64 | |
| 11 | 2016 | 25 | |
| 12 | 2016 | 3 | |
| 13 | 2015 | 18 | |
| 14 | 2015 | 12 | |
| 15 | 2015 | 2 | |
| 16 | 2015 | 41 | |
| 17 | 2011 | 11 | |
| 18 | Polymorphisms contribution to the determination of significant risk of specific toxicities in multiple myeloma. | 2011 | 1 |
| 19 | 2009 | 26 | |
| 20 | 2009 | 18 |
About Martina Almáši
Martina Almáši is a scholar working on Hematology, Cancer Research and Genetics, having authored 29 papers that have together received 491 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Genomics and Diagnostics (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Mechanisms and Therapy (2 papers), MicroRNA in disease regulation (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). The work is most often cited by research in Hematology (291 citations), Cancer Research (136 citations) and Biological Psychiatry (20 citations). Martina Almáši has collaborated with scholars based in Czechia, United States and Japan. Frequent co-authors include Luděk Pour, Roman Hájek, Sabina Ševčı́ková, Petr Kuglík, Miroslav Penka, Lenka Sedlaříková, Martin Štork, Viera Sandecká, Veronika Vidová and Zdeněk Spáčil. Their work appears in journals such as Blood, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.